<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04433585</url>
  </required_header>
  <id_info>
    <org_study_id>17422</org_study_id>
    <secondary_id>J1P-MC-KFAJ</secondary_id>
    <secondary_id>2019-003323-38</secondary_id>
    <nct_id>NCT04433585</nct_id>
  </id_info>
  <brief_title>A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)</brief_title>
  <acronym>ISLAND-SLE</acronym>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nektar Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Eli Lilly and Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The reason for this study is to see if the study drug LY3471851 (NKTR-358) is safe and
      effective in adults with systemic lupus erythematosus (SLE).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      LY3471851 is a potential first-in-class therapeutic that may address an underlying immune
      system imbalance in people with many autoimmune conditions. It targets the interleukin (IL-2)
      receptor complex in the body in order to stimulate proliferation of inhibitory immune cells
      known as regulatory T cells. By activating these cells, LY3471851 may act to bring the immune
      system back into balance.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 4, 2020</start_date>
  <completion_date type="Anticipated">April 27, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 19, 2023</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants who Achieve a ≥4 Point Reduction in Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) 2000 (2K) Score</measure>
    <time_frame>Week 24</time_frame>
    <description>Percentage of Participants who Achieve a ≥4 Point Reduction in SLEDAI-2K Score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants who Achieve British Isles Lupus Assessment Group (BILAG) Based Composite Lupus Assessment (BICLA) Response</measure>
    <time_frame>Week 24</time_frame>
    <description>Percentage of Participants who Achieve BICLA Response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants who Achieve Systemic Lupus Erythematosus Responder Index 4 (SRI-4) Response</measure>
    <time_frame>Week 24</time_frame>
    <description>Percentage of Participants who Achieve SRI-4 Response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants who Achieve Lupus Low Disease Activity State (LLDAS)</measure>
    <time_frame>Week 24</time_frame>
    <description>Percentage of Participants who Achieve LLDAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pharmacokinetics (PK): Trough Concentrations (Ctrough) of LY3471851</measure>
    <time_frame>Week 24</time_frame>
    <description>PK: Ctrough of LY3471851</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <arm_group>
    <arm_group_label>LY3471851 High Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LY3471851 administered subcutaneously (SC).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LY3471851 Mid Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LY3471851 administered SC.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LY3471851 Low Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LY3471851 administered SC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo administered SC.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LY3471851</intervention_name>
    <description>Administered SC</description>
    <arm_group_label>LY3471851 High Dose</arm_group_label>
    <arm_group_label>LY3471851 Low Dose</arm_group_label>
    <arm_group_label>LY3471851 Mid Dose</arm_group_label>
    <other_name>NKTR-358</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administered SC</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have a clinical diagnosis of SLE at least 24 weeks prior to screening.

          -  Have documentation of having met at least 4 of 11 Revised Criteria for Classification
             of Systemic Lupus Erythematosus according to the 1997 Update of the 1982 American
             College of Rheumatology (ACR) criteria for classification of SLE prior to
             randomization.

          -  Have a positive antinuclear antibody (ANA) (titer ≥1:80) and/or a positive
             anti-double-stranded deoxyribonucleic acid (dsDNA), and/or a positive anti-Smith
             (anti-Sm) as assessed by a central laboratory during screening.

          -  Have a total Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K)
             score ≥6 during screening.

          -  Have a clinical SLEDAI-2K score ≥4 at randomization.

          -  Have active arthritis and/or active rash.

        Exclusion Criteria:

          -  Have severe active lupus nephritis.

          -  Have active central nervous system (CNS) lupus.

          -  Have a history or presence of cardiovascular, respiratory, hepatic, gastrointestinal,
             endocrine, hematological, neurological, or neuropsychiatric disorders or any other
             serious and/or unstable illness that, in the opinion of the investigator, could
             constitute an unacceptable risk when taking investigational product or interfere with
             the interpretation of data.

          -  Have a current or recent clinically serious viral, bacterial, fungal, or parasitic
             infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)</last_name>
    <role>Study Director</role>
    <affiliation>Eli Lilly and Company</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>There may be multiples sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or</last_name>
    <phone>1-317-615-4559</phone>
    <email>clinicaltrials.gov@lilly.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California - San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>858-246-2386</phone>
    </contact>
    <investigator>
      <last_name>Chelsey Smith</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Desert Medical Advances</name>
      <address>
        <city>Palm Desert</city>
        <state>California</state>
        <zip>92260</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>760-341-6800</phone>
    </contact>
    <investigator>
      <last_name>Maria Greenwald</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University Hospital</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>650-723-6961</phone>
    </contact>
    <investigator>
      <last_name>Yashaar Chaichian</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inland Rheumatology Clinical Trials</name>
      <address>
        <city>Upland</city>
        <state>California</state>
        <zip>91786</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>909-982-0099</phone>
    </contact>
    <investigator>
      <last_name>Antony Hou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado School of Medicine</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>303-724-1919</phone>
    </contact>
    <investigator>
      <last_name>Susan Boackle</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Center of CT/NY</name>
      <address>
        <city>Danbury</city>
        <state>Connecticut</state>
        <zip>06810</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>203-616-2710</phone>
    </contact>
    <investigator>
      <last_name>Richard Roseff</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>20368006520</phone>
    </contact>
    <investigator>
      <last_name>Fotios Koumpouras</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stamford Therapeutics Consortium</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <zip>06905</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>203-325-8529</phone>
    </contact>
    <investigator>
      <last_name>Stuart Novack</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>305-243-0151</phone>
    </contact>
    <investigator>
      <last_name>Maria Carpintero</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Horizon Research Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33165</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>305-226-3933</phone>
    </contact>
    <investigator>
      <last_name>Lazaro Nunez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>617-667-5619</phone>
    </contact>
    <investigator>
      <last_name>Vasileios Kyttaris</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NECCR PrimaCare Research, LLC</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02721</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>508-646-7615</phone>
    </contact>
    <investigator>
      <last_name>Mark Fisher</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>734-936-5561</phone>
    </contact>
    <investigator>
      <last_name>William J McCune</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>314-273-8259</phone>
    </contact>
    <investigator>
      <last_name>Reema Syed</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11021</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>5167082550</phone>
    </contact>
    <investigator>
      <last_name>Richard Alan Furie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>646-501-7400</phone>
    </contact>
    <investigator>
      <last_name>Amit Saxena</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MetroHealth Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>216-778-5154</phone>
    </contact>
    <investigator>
      <last_name>Stanley P Ballou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Paramount Medical Research</name>
      <address>
        <city>Middleburg Heights</city>
        <state>Ohio</state>
        <zip>44130</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>440-826-0742</phone>
    </contact>
    <investigator>
      <last_name>Isam A. Diab</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oklahoma Medical Research Foundation</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104-5046</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>405-271-7805</phone>
    </contact>
    <investigator>
      <last_name>Cristina Arriens</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Accurate Clinical Management LLC - BayTown</name>
      <address>
        <city>Baytown</city>
        <state>Texas</state>
        <zip>77521</zip>
        <country>United States</country>
      </address>
    </facility>
    <investigator>
      <last_name>Sabeen Najam</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Metroplex Clinical Research Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>214796737</phone>
    </contact>
    <investigator>
      <last_name>Sharad Lakhanpal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>241-648-4948</phone>
    </contact>
    <investigator>
      <last_name>David Karp</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Accurate Clinical Research</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77089</zip>
        <country>United States</country>
      </address>
    </facility>
    <investigator>
      <last_name>Philip A Waller</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195-6422</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>206-685-9985</phone>
    </contact>
    <investigator>
      <last_name>Kwanghoon Han</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DOM- Centro de Reumatologia</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>1111</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <contact>
      <phone>541121203180</phone>
    </contact>
    <investigator>
      <last_name>Cecilia Asnal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aprillus Asistencia e Investigacion - Servicio de neurologia</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>C1046AAQ</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <contact>
      <phone>542644211086</phone>
    </contact>
    <investigator>
      <last_name>Pablo Mannucci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica Adventista de Belgrano</name>
      <address>
        <city>Ciudad Autonoma Buenos Aires</city>
        <zip>C1430EGF</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <contact>
      <phone>541140141500</phone>
    </contact>
    <investigator>
      <last_name>Federico Javier Ariel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Ramos Mejia</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aire</city>
        <zip>C1221ADC</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <contact>
      <phone>541149311178</phone>
    </contact>
    <investigator>
      <last_name>Eduardo Kerzberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro de Medicina Familiar Mindout Research</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aire</city>
        <zip>C1417EYG</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <contact>
      <phone>541145023759</phone>
    </contact>
    <investigator>
      <last_name>Leonardo Naftal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Cordoba</name>
      <address>
        <city>Cordoba</city>
        <zip>X5004CDT</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <contact>
      <phone>03514533042</phone>
    </contact>
    <investigator>
      <last_name>Veronica Savio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Polivalente de Asistencia e Inv. Clinica CER-San Juan</name>
      <address>
        <city>San Juan</city>
        <zip>J5402DIL</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <contact>
      <phone>542644211086</phone>
    </contact>
    <investigator>
      <last_name>Rodolfo Ariel Pardo Hidalgo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Medico Privado de Reumatologia</name>
      <address>
        <city>Tucuman</city>
        <zip>T4000AXL</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <contact>
      <phone>543814200180</phone>
    </contact>
    <investigator>
      <last_name>Horacio Berman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Interni a revmatologicka ambulance, Inrea s.r.o.</name>
      <address>
        <city>Ostrava</city>
        <zip>703 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <contact>
      <phone>420595957373</phone>
    </contact>
    <investigator>
      <last_name>Martina Malcova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Revmatologicky ustav</name>
      <address>
        <city>Praha 2</city>
        <zip>12800</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <contact>
      <phone>00420234075462</phone>
    </contact>
    <investigator>
      <last_name>Marta Olejarova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tübingen</city>
        <state>Baden-Württemberg</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <phone>0049 70712984095</phone>
    </contact>
    <investigator>
      <last_name>Jörg Henes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rheumazentrum Ruhrgebiet</name>
      <address>
        <city>Herne</city>
        <state>Nordrhein-Westfalen</state>
        <zip>44649</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <phone>492325592138</phone>
    </contact>
    <investigator>
      <last_name>Uta Kiltz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universtitätsklinikum Essen AöR</name>
      <address>
        <city>Essen</city>
        <state>North Rhine-Westphalia</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <phone>492017233394</phone>
    </contact>
    <investigator>
      <last_name>Sebastian Dolff</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rheumaklinik Bad Branstedt GmbH</name>
      <address>
        <city>Bad Bramstedt</city>
        <state>Schleswig-Holstein</state>
        <zip>24576</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <phone>0049419 2900</phone>
    </contact>
    <investigator>
      <last_name>Ina Kotter</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Innere Medizin I, Universitätsklinikum Schleswig-Holstein, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <phone>0049431 50022203</phone>
    </contact>
    <investigator>
      <last_name>Bimba Hoyer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Köln</name>
      <address>
        <city>Köln</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <phone>00492214784427</phone>
    </contact>
    <investigator>
      <last_name>David Kofler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bekes Megyei Pandy Kalman Korhaz</name>
      <address>
        <city>Gyula</city>
        <state>Bekes</state>
        <zip>5700</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <contact>
      <phone>3666526526</phone>
    </contact>
    <investigator>
      <last_name>Tibor Martyin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Qualiclinic Kft</name>
      <address>
        <city>Budapest</city>
        <zip>1036</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <contact>
      <phone>36309606109</phone>
    </contact>
    <investigator>
      <last_name>Istvan Szombathi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem Orvos-es Egészsegtudomanyi Centrum</name>
      <address>
        <city>Debrecen</city>
        <zip>4004</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <contact>
      <phone>003652255 000 ext 54894</phone>
    </contact>
    <investigator>
      <last_name>Tünde Tarr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>3109601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <phone>972-4-8542268</phone>
    </contact>
    <investigator>
      <last_name>Yolanda Braun Moscovici</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>5265601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <phone>972 3 5302156</phone>
    </contact>
    <investigator>
      <last_name>Merav Lidar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kojunkai Daido Clinic</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <zip>4570818</zip>
        <country>Japan</country>
      </address>
    </facility>
    <contact>
      <phone>81120023812</phone>
    </contact>
    <investigator>
      <last_name>Yoichiro Haji</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Chiba-East-Hospital</name>
      <address>
        <city>Chuo-ku</city>
        <state>Chiba</state>
        <zip>260-8712</zip>
        <country>Japan</country>
      </address>
    </facility>
    <contact>
      <phone>81120023812</phone>
    </contact>
    <investigator>
      <last_name>Ryutaro Matsumura</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Lukes International Hospital</name>
      <address>
        <city>Chuo-Ku</city>
        <state>Tokyo</state>
        <zip>104 8560</zip>
        <country>Japan</country>
      </address>
    </facility>
    <contact>
      <phone>81120023812</phone>
    </contact>
    <investigator>
      <last_name>Atsushi Nomura</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Keio University Hospital</name>
      <address>
        <city>Shinjuku-Ku</city>
        <state>Tokyo</state>
        <zip>160-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
    <contact>
      <phone>81120023812</phone>
    </contact>
    <investigator>
      <last_name>Yuko Kaneko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Kyushu Medical Center</name>
      <address>
        <city>Fukuoka</city>
        <zip>810 8563</zip>
        <country>Japan</country>
      </address>
    </facility>
    <contact>
      <phone>81120023812</phone>
    </contact>
    <investigator>
      <last_name>Tomoya Miyamura</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Okayama University Hospital</name>
      <address>
        <city>Okayama</city>
        <zip>700-8558</zip>
        <country>Japan</country>
      </address>
    </facility>
    <contact>
      <phone>81120023812</phone>
    </contact>
    <investigator>
      <last_name>Yoshinori Matsumoto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NTT West Osaka Hospital</name>
      <address>
        <city>Osaka</city>
        <zip>543-0042</zip>
        <country>Japan</country>
      </address>
    </facility>
    <contact>
      <phone>81120023812</phone>
    </contact>
    <investigator>
      <last_name>Atsushi Ogata</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NTT West Osaka Hospital</name>
      <address>
        <city>Osaka</city>
        <zip>543-0042</zip>
        <country>Japan</country>
      </address>
    </facility>
    <contact>
      <phone>81667737111</phone>
    </contact>
    <investigator>
      <last_name>Atsushi Ogata</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <phone>82317877432</phone>
    </contact>
    <investigator>
      <last_name>Yun Jong Lee</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inha University Hospital</name>
      <address>
        <city>Incheon</city>
        <state>Korea</state>
        <zip>22332</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <phone>82328903483</phone>
    </contact>
    <investigator>
      <last_name>Won Park</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hanyang University Medical Center</name>
      <address>
        <city>Seoul</city>
        <state>Korea</state>
        <zip>04763</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <contact>
      <phone>82222909202</phone>
    </contact>
    <investigator>
      <last_name>Sang-Cheol Bae</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Medico del Angel S.C.</name>
      <address>
        <city>Mexicali</city>
        <state>Baja California</state>
        <zip>21100</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <phone>526865529404</phone>
    </contact>
    <investigator>
      <last_name>Beatriz E Zazueta Montiel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr. Alberto Esteban Bazzoni Ruiz</name>
      <address>
        <city>Torreon</city>
        <state>Coahuila</state>
        <zip>27000</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <phone>528717130315</phone>
    </contact>
    <investigator>
      <last_name>Sandra Araceli Sicsik Ayala</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>RM Pharma Specialists S.A. de C.V.</name>
      <address>
        <city>Mexico City</city>
        <state>Distrito Federal</state>
        <zip>03100</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <phone>525553364206</phone>
    </contact>
    <investigator>
      <last_name>Jaime Reyes Gonzaga</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica para el Diagnostico y Tratamiento de la Enfermedades</name>
      <address>
        <city>Mexico City</city>
        <state>Distrito Federal</state>
        <zip>06700</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <phone>5255337477</phone>
    </contact>
    <investigator>
      <last_name>Gabriel Medrano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Integral en Reumatologia SA de CV</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44160</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <phone>526646340662</phone>
    </contact>
    <investigator>
      <last_name>Hilario Avila-Armengol</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica en Investigación en Reumatologia y Obesidad S.C.</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44650</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <contact>
      <phone>523338250000</phone>
    </contact>
    <investigator>
      <last_name>Sergio Duran Barragan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barbara Rewerska DIAMOND CLINIC</name>
      <address>
        <city>Krakow</city>
        <state>Malopolskie</state>
        <zip>31-559</zip>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <phone>48122651165</phone>
    </contact>
    <investigator>
      <last_name>Barbara Rewerska</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medycyna Kliniczna</name>
      <address>
        <city>Warszawa</city>
        <state>Mazowieckie</state>
        <zip>00874</zip>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <phone>48226291354</phone>
    </contact>
    <investigator>
      <last_name>Katarzyna Romanowska-Prochnicka</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reuma Clinic</name>
      <address>
        <city>Bialystok</city>
        <state>Podlaskie</state>
        <zip>15-166</zip>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <phone>48518630640</phone>
    </contact>
    <investigator>
      <last_name>Izabela Domyslawska</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersytecki nr 2 im. dr J. Biziela</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-168</zip>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <phone>48668344681</phone>
    </contact>
    <investigator>
      <last_name>Rafal Wojciechowski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nzoz Bif-Med</name>
      <address>
        <city>Bytom</city>
        <zip>41-902</zip>
        <country>Poland</country>
      </address>
    </facility>
    <contact>
      <phone>48508270636</phone>
    </contact>
    <investigator>
      <last_name>Hanna Mastalerz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Office: Perez-De Jesus, Amarilis</name>
      <address>
        <city>Caguas</city>
        <zip>00725</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <contact>
      <phone>7872868465</phone>
    </contact>
    <investigator>
      <last_name>Amarilis Perez-De Jesus</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Latin Clinical Trial Center</name>
      <address>
        <city>San Juan</city>
        <zip>00909</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <contact>
      <phone>7872494763</phone>
    </contact>
    <investigator>
      <last_name>Carlos A Pantojas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GCM Medical Group PSC</name>
      <address>
        <city>San Juan</city>
        <zip>00917</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <contact>
      <phone>7877268396</phone>
    </contact>
    <investigator>
      <last_name>Karina Vila-Rivera</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mindful Medical Research</name>
      <address>
        <city>San Juan</city>
        <zip>00918</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <contact>
      <phone>7877659034</phone>
    </contact>
    <investigator>
      <last_name>Oscar Soto-Raices</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrul Medical de Diagnostic si Tratament Ambulatoriu Neomed SRL</name>
      <address>
        <city>Brasov</city>
        <zip>500283</zip>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <phone>40368424168</phone>
    </contact>
    <investigator>
      <last_name>Liliana Duca</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SC Centrul Medical Sana SRL</name>
      <address>
        <city>Bucuresti</city>
        <zip>011025</zip>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <phone>40212128222</phone>
    </contact>
    <investigator>
      <last_name>Cristina Pop</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Sf Maria Bucuresti</name>
      <address>
        <city>Bucuresti</city>
        <zip>011172</zip>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <phone>40722858076</phone>
    </contact>
    <investigator>
      <last_name>Daniela Opris-Belinski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Sf Maria Bucuresti</name>
      <address>
        <city>Bucuresti</city>
        <zip>011172</zip>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <phone>40723236258</phone>
    </contact>
    <investigator>
      <last_name>Florian Berghea</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta &quot;Sf.Apostol Andrei&quot; Compartimentul Reumatologie</name>
      <address>
        <city>Galati</city>
        <zip>800578</zip>
        <country>Romania</country>
      </address>
    </facility>
    <contact>
      <phone>40236315151</phone>
    </contact>
    <investigator>
      <last_name>Mariana Pavel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital #15 named after O.M. Filatov</name>
      <address>
        <city>Moscow</city>
        <zip>111539</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <contact>
      <phone>+7 495 918 72 84</phone>
    </contact>
    <investigator>
      <last_name>Ivan Gordeev</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>V.A. Nasonova Research Institute of Rheumatology</name>
      <address>
        <city>Moscow</city>
        <zip>115522</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <contact>
      <phone>+7 499 109 29 10</phone>
    </contact>
    <investigator>
      <last_name>Tatyana Reshetnyak</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Republican Hospital named after V.A. Baranov</name>
      <address>
        <city>Petrozavodsk</city>
        <zip>185019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <contact>
      <phone>+7 814 276 42 88</phone>
    </contact>
    <investigator>
      <last_name>Natalia Vezikova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ryazan Regional Clinincal Cardiology Dispensary</name>
      <address>
        <city>Ryazan</city>
        <zip>390026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <contact>
      <phone>74912975178</phone>
    </contact>
    <investigator>
      <last_name>Sergey Yakushin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Infanta Luisa</name>
      <address>
        <city>Sevilla</city>
        <zip>41010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <phone>34954330100 ext 461</phone>
    </contact>
    <investigator>
      <last_name>Juan Miguel Sanchez Burson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital - Kaohsiung Branch</name>
      <address>
        <city>Kaohsiung City</city>
        <zip>83301</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <phone>88677317123</phone>
    </contact>
    <investigator>
      <last_name>Wen-Chan Chiu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>China Medical University Hospital</name>
      <address>
        <city>Taichung City</city>
        <zip>40447</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <phone>886422052121#3210</phone>
    </contact>
    <investigator>
      <last_name>Joung-Liang Lan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Taichung Veterans General Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>40705</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <phone>886423592525</phone>
    </contact>
    <investigator>
      <last_name>Wen-Nan Huang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei City</city>
        <zip>10048</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <phone>886933688744</phone>
    </contact>
    <investigator>
      <last_name>Song-Chou Hsieh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regional Clinical Hospital Center for Emergency medical care</name>
      <address>
        <city>Kharkiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <contact>
      <phone>+380500840986</phone>
    </contact>
    <investigator>
      <last_name>Svitlana Trypilka</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Scientific Center &quot;Strazhesko institute of cardio&quot;</name>
      <address>
        <city>Kyiv</city>
        <zip>03680</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <contact>
      <phone>+38 (044) 249-70-32</phone>
    </contact>
    <investigator>
      <last_name>Olena Garmish</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyiv City Clinical Hospital #3</name>
      <address>
        <city>Kyiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <contact>
      <phone>+380674413607</phone>
    </contact>
    <investigator>
      <last_name>Oleh Iaremenko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Multifield Medical Center of Odesa NMU (University Clinic#1)</name>
      <address>
        <city>Odesa</city>
        <zip>65026</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <contact>
      <phone>380487185377</phone>
    </contact>
    <investigator>
      <last_name>Viktoria Vasylets</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Czechia</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Mexico</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Taiwan</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://trials.lillytrialguide.com/en-US/trial/2NrKmN7Zwj52k3UG9QrLqS?conditionId=3a2yMNGWXSa2MGcsES0aOu</url>
    <description>A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) (ISLAND-SLE)</description>
  </link>
  <verification_date>July 15, 2020</verification_date>
  <study_first_submitted>June 15, 2020</study_first_submitted>
  <study_first_submitted_qc>June 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2020</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>T regulatory cells (Tregs)</keyword>
  <keyword>Interleukin 2</keyword>
  <keyword>Interleukin-2</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data are available 6 months after the primary publication and approval of the indication studied in the US and EU, whichever is later. Data will be indefinitely available for requesting.</ipd_time_frame>
    <ipd_access_criteria>A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.</ipd_access_criteria>
    <ipd_url>https://vivli.org/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

